Nanil Therapeutics Inc.

Visitez le site Web

Drug development for the brain is notoriously slow, costly, and high-risk due to the complexity of the central nervous system and barriers like the blood-brain barrier. We develop new tools, new approaches, and new thinking to break this cycle.